Free shipping on all orders over $ 500

ML327

Cat. No. M9309

All AbMole products are for research use only, cannot be used for human consumption.

ML327 Structure
Synonym:

ML-327

Size Price Availability Quantity
10mM*1mL in DMSO USD 150 In stock
5mg USD 140 In stock
10mg USD 210 In stock
25mg USD 440 In stock
50mg USD 700 In stock
100mg USD 1100 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

ML327 is a blocker of MYC, which mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition. ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand. ML327 blocks the expression of MYC family of oncogenic transcription factors in all tested neuroblastoma cell lines. ML327 reduces SW620inv cell invasion through Matrigel by ~60% and reduces H520 cell invasion by ~30% in these in vitro assays.

In vivo, ML327 treatment significantly reduces tumor volume by three-fold over the two-week treatment period (p=0.02). Tumor explant weights are approximately three-fold smaller in the ML327-treated mice (p=0.01). Mice treated with ML327 lost 12% more body weight than vehicle treated mice.

Chemical Information
Molecular Weight 366.37
Formula C19H18N4O4
CAS Number 1883510-31-3
Solubility (25°C) DMSO: ≥ 21 mg/mL (Need warming)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Rellinger EJ, et al. Oncotarget. Isoxazole compound ML327 blocks MYC expression and tumor formation in neuroblastoma.

[2] Rellinger EJ, et al. Biochem Biophys Res Commun. ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand.

[3] An H, et al. Oncotarget. Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition.

Related c-Myc Products
10058-F4

10058-F4 is a c-Myc inhibitor that specificallly inhibits the c-Myc-Max interaction and prevents transactivation of c-Myc target gene expression.

10074-G5

10074-G5 is a c-Myc/Max interaction inhibitor, which binds to a different specific binding site (region) of C-Myc than 10054-F4.

MYCi975

MYCi975 (Nuc-0200975) is an orally active MYC inhibitor that disrupts MYC/MAX interactions, promotes MYC T58 phosphorylation and MYC degradation, and impairs myC-driven gene expression. MYCi975 (NUC-0200975) has strong anti-tumor effect and good tolerance, increasing tumor immune cell infiltration and enhancing tumor sensitivity against PD1 immune studies.

APTO-253

APTO-253 (LOR-253) is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells.

IZCZ-3

IZCZ-3 is a potent c-MYC transcription inhibitor with antitumor activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: ML327, ML-327 supplier, c-Myc, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.